News Videos
World
International Edition

Thursday

September 21, 2017

Breaking News, World News and Taiwan News.
About Us
E-Newsletter
Advertise
Contact Us

AstraZeneca shares plunge 14% after snub to raised Pfizer bid

LONDON--The share price of British drugmaker AstraZeneca slumped on Monday after it rejected a final takeover bid from U.S. rival Pfizer worth US$117 billion.

The shares tumbled 13.99 percent to 41.49 pounds in early morning deals on London's FTSE 100 index of leading companies, which was down 0.49 percent at 6,822.25 points.

AstraZeneca on Monday rejected a final takeover bid from Pfizer that was pitched at 55 pounds per share, valuing the British firm at 69 billion pounds.

Pfizer had made an improved and final offer on Sunday, but warned that it would not proceed without a recommendation from AstraZeneca management.

MOST POPULAR OF THIS SECTION
Advertise  |   RSS Feed  |   About Us  |   Contact Us
Home  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |  
Arts & Leisure  |   Health  |   Editorial  |   Commentary Travel  |   Movies  |   Guide Post  |   Terms of Use  |  
  chinapost search